Meet with our product experts in one-on-one virtual sessions

Set Up a Meeting
快速连接

Central Nervous System API Products

Central Nervous System API Products

Central Nervous System API Products
Central Nervous System API Products

USPs of our CNS APIs

  • Firm PSD control to help maintain consistency of manufacturing process.
  • Sufficient capacity to meet our customer’s global leadership requirements.
  • Reliable KSM suppliers in India with timely deliveries and stringent specifications.
  • IP compliant process.
  • Well-controlled all the plausible impurities within the specified limit.
  • Commercially available starting materials.
  • Schemes of starting material evaluated.
  • Flexible business models to support registrations.
  • Adequate capacity available to supply development quantity in short lead time.
  • Free from nitrosamine impurities.
  • QBD (Quality by Design) based API development for consistent quality profile.
  • Continuous improvement in place to achieve cost and quality excellence.
  • Process safety and scalability.
  • APIs suitable for global formulation development.
  • Fully backward integration process.
  • Compliant to all pharmacopeia’s.
  • Multiple domestic sources for KSMs available.
  • Able to match a wide range of particle size requirements.

Get access to Dr. Reddy's largest CNS API portfolios to support your formulation success

Dr. Reddy’s is one of the leading generic pharmaceutical companies and CNS API suppliers in the development and manufacturing of CNS APIs used in formulations to treat indications in the central nervous system (CNS) therapy area. Our CNS API product portfolio is broad-based, including APIs in the class of atypical antipsychotics, anticholinergics, Nrf2 activators, cholinesterase inhibitors, antioxidants, and GnRH antagonists.

As CNS API manufacturer and supplier, Dr. Reddys CNS APIs for various therapeutic categories are as follows:

Bipolar Disorder/ Anti-schizophrenic
 

Bipolar Disorder/ Anti-schizophrenic - Dr. Reddy's

*Countries referred in the above graphic denotes DMF filing geographies

Anti-Parkinson’s

Anti-Parkinson’s - Dr. Reddy's

*Countries referred in the above graphic denotes DMF filing geographies

Anti-ALS

Anti-ALS - Dr. Reddy's

*Countries referred in the above graphic denotes DMF filing geographies

Multiple Sclerosis

Multiple Sclerosis - Dr. Reddy's

*Countries referred in the above graphic denotes DMF filing geographies

Anti-Alzheimer’s

Anti-Alzheimer’s - Dr. Reddy's

*Countries referred in the above graphic denotes DMF filing geographies

Major Depressive Disorder

Major Depressive Disorder - Dr. Reddy's

*Countries referred in the above graphic denotes DMF filing geographies

Pain Management

Pain Management - Dr. Reddy's

*Countries referred in the above graphic denotes DMF filing geographies

Anti-epileptic

Anti-epileptic - Dr. Reddy's

*Countries referred in the above graphic denotes DMF filing geographies

Anti-migraine

Anti-migraine - Dr. Reddy's

*Countries referred in the above graphic denotes DMF filing geographies

Explore other Therapeutic categories.

Explore

FAQs

Our CNS API product portfolio is broad-based, including APIs in the class of atypical antipsychotics, anticholinergics, Nrf2 activators, cholinesterase inhibitors, antioxidants, and GnRH antagonists.

They can act either as neurotransmitter agonists, such as the opioids, which mimic the action of enkephalin, or they can block receptor function. Receptor antagonism is a common mechanism of action for CNS drugs.

The global central nervous system therapeutic market was valued at 116.2 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 7.4% from 2021 to 2028. Advancements in diagnostics and therapeutics of CNS diseases are expected to increase the treatment rate globally.

Used to treat insomnia (trouble sleeping), anxiety, panic attacks, and seizures. They may also be used to relieve anxiety and tension before surgery. Examples of CNS depressants are benzodiazepines, barbiturates, and certain sleep medicines.

Meet with our product experts in one-on-one virtual sessions

Our experts will answer your questions, provide advice, and help you understand our product better

Set Up a Meeting

免责声明

本目錄中的任何信息（包括對任何產品或服務的任何引用）均不構成銷售要約，或被解釋為代表銷售要約。受有效專利保護的產品不提供或供應用於商業用途。但是，只要存在此類監管豁免，就可以出於監管提交的目的提供此類產品的研究數量。買方應對各自市場的專利方案進行獨立評估，並承擔所有與專利相關的責任。在印度受有效專利保護的產品不可用於商業用途，但可用於第 107A 節。